bluebird bio

bluebird bio

bluebird bio

bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.
Founded
1992
Raised
$384.3M
Follow us
Alexa global traffic share
Twitter followers
07 Dec 2016
$250,000,000
Post-IPO equity

Boston Business on Twitter

Twitter
27 Oct 2012
25 Jul 2012
$60,000,000
Venture capital (Series D)
20 Apr 2011
12 Mar 2010
$35,000,000
Venture capital (Series B)